Small cell carcinoma of the bladder: Long term outcome with integrated chemoradiation

Cancer

Volumn 86, Issue 11, 1999, Pages 2346-2352

  Lohrisch, Caroline ^a,c   Murray, Nevin ^a   Pickles, Tom ^a   Sullivan, Lorne ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c EORTC DATA CENTER   (Belgium)

Author keywords

Chemotherapy; Genitourinary neoplasm; Radiation; Small cell carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; LYMPH NODE METASTASIS; MALE; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SECOND CANCER; SMALL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; EPIRUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0033429880     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>3.0.CO;2-5     Document Type: Article

References (24)

1. Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive cancer of the urinary bladder. Cancer 1981;47:724-30.
2. Podesta AH, True LD. Small cell carcinoma of the bladder: report of five cases with immunohistochemistry and review of literature with evaluation of prognosis according to stage. Cancer 1989;64:710-4.
3. Lopez JI, Angulo JC, Flores N, Toledo JD. Small cell carcinoma of the urinary bladder. A clinocopathological study of six cases. Br J Urol 1994;73:43-9.
4. Mills SE, Wolfe JT III, Weiss MA, Swanson PE, Wick MR, Fowler JE Jr., et al. Small cell undifferentiated carcinoma of the urinary bladder: a light-microscopic, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1987;11:606-17.
5. Blomjous CE, Vos W, Schipper NW, DeVoogt HJ, Baak JP, Meijer CJ. Morphometric and flow cytometric analysis of small cell undifferentiated carcinoma of the bladder. J Clin Pathol 1989;4:1032-9.
6. Blomjous CE, Vos W, De Voogt HJ, Van Der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder: a clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 1989;64:1347-57.
7. Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordonez NG, Logothetis CJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 22 cases. Cancer 1992;69:527-36.
8. Holmang S, Borghede G, Johansson SL. Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol 1995; 153:1820-2.
9. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79(9):1729-36.
10. Ali SZ, Reuter VE, Zakowski MF. Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer 1997;79(2):356-61.
11. Oesterling JE, Brendler CB, Burgers JK, Marshall FF, Epstein JI. Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer 1990;65:1928-36.
12. Abbas F, Civantos F, Benedetto P, Soloway MS. Small cell carcinoma of the bladder and prostate. Urology 1995;46(5): 617-30.
13. Li-Wend D, Unger P, Forscher C, Fine E. Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy. J Urol 1995;153:417-9.
14. Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. J Clin Oncol 1993;11:336-44.
15. Turrisi A, Kim K, Sause W, Komaki R, Wagner H, Aisner R, et al. Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin etoposide and concurrent 45 Gy thoracic radiotherapy given in daily or twice-daily fractions followed by 25 Gy PCI. Survival differences and patterns of failure [abstract 1757]. Proc ASCO 1998;17:457a.
16. Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie M, et al. New combination of the old drugs for elderly patients with small-cell lung cancer: a Phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-7.
17. Harker WG, Meyers FJ, Freha FS, Palmer JM, Shortliffe LD, Hannigan JF, et al. Cisplatin, methotrexate and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. J Clin Oncol 1985;3:1463-70.
18. Shepherd FA, Ginsberg RJ, Haddad R, Feld R, Sagman U, Evans WK, et al. Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. J Clin Oncol 1993;11:1592-7.
19. Sagman U, Feld R, Evans WK, Warr D, Shepherd FA, Payne D, et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small cell lung cancer. J Clin Oncol.1991;9:954-61.
20. Murray N, Shah A, Brown E, Kostachuk E, Laukkanen E, Goldie J, et al. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited stage small cell carcinoma of the lung. Semin Oncol 1986; 13:24-30.
21. Feld R, Evans WK, Coy P, Hodson I, MacDonald AS, Osoba D, et al. Canadian multi-center randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small cell carcinoma of the lung. JCO1987;5(9):1401-9.
22. Evans WK, Feld K, Murray N, Willam A, Coy P, Osoba D, et al. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. Ann Intern Med 1987;107:451-8.
23. Wiernik G, Bates TD, Bleehen NM, Brindle JM, Bullimore J, Fowler JF, et al. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/ week versus 5F/week in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1990;63(747):169-80.
24. Tucker MA, Murray N, Shaw EG, Ettinger DS, Mabry M, Huber MH, et al. Second primary cancers related to smoking and treatment for small-cell lung cancer. J Natl Cancer Inst 1997;89:1782-8.